Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tea JS"'
Autor:
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. t.powles@qmul.ac.uk., Kockx M; HistogeneX N.V, Wilrijk, Belgium., Rodriguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain., Duran I; Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain., Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Pous AF; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Gravis G; Institut Paoli-Calmettes, Marseille, France., Herranz UA; Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain., Protheroe A; Department of Medical Oncology, Churchill Hospital, Oxford, UK., Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France., Maillet D; Department of Medical Oncology, Hospital Lyon Sud, Lyon, France., Mendez MJ; Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain., Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain., Linch M; Department of Medical Oncology, University College London Hospital, London, UK., Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., van Dam PJ; HistogeneX N.V, Wilrijk, Belgium., Stanoeva D; HistogeneX N.V, Wilrijk, Belgium., Daelemans S; HistogeneX N.V, Wilrijk, Belgium.; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium., Mariathasan S; Genentech, San Francisco, CA, USA., Tea JS; Genentech, San Francisco, CA, USA., Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Banchereau R; Genentech, San Francisco, CA, USA., Castellano D; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
Publikováno v:
Nature medicine [Nat Med] 2023 Dec; Vol. 29 (12), pp. 3271.
Autor:
Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Kockx M; CellCarta N V, Wilrijk, Belgium., Assaf ZJ; Genentech, San Francisco, CA, USA., van Dam PJ; CellCarta N V, Wilrijk, Belgium., Rodriguez-Vida A; Hospital del Mar, Barcelona, Spain., Duran I; Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville, Spain., Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Pous AF; Institut Catala d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Gravis G; Institut Paoli-Calmettes, Marseille, France., Herranz UA; Hospital Clinico Universitario de Santiago, Santiago De Compostela, Spain., Protheroe A; Churchill Hospital, Oxford, UK., Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU, Bordeaux, France., Maillet D; Hospital Lyon SUD, Lyon, France., Mendez MJ; Reina Sofia University Hospital, Cordoba, Spain., Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain., Linch M; UCLH, London, UK., Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Tyson C; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Stanoeva D; CellCarta N V, Wilrijk, Belgium., Daelemans S; CellCarta N V, Wilrijk, Belgium; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium., Rombouts M; CellCarta N V, Wilrijk, Belgium., Mariathasan S; Genentech, San Francisco, CA, USA., Tea JS; Genentech, San Francisco, CA, USA., Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Sharma S; Natera, Inc., San Carlos, CA, USA., Aleshin A; Natera, Inc., San Carlos, CA, USA., Banchereau R; Genentech, San Francisco, CA, USA., Castellano D; Hospital 12 de Octubre, Madrid, Spain., Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. Electronic address: thomas.powles1@nhs.net.
Publikováno v:
European urology [Eur Urol] 2022 Aug; Vol. 82 (2), pp. 212-222. Date of Electronic Publication: 2022 May 14.
Autor:
Wang H; Skirball Institute for Biomolecular Medicine and Department of Cell Biology, NYU Grossman School of Medicine, 540 First Avenue, New York, NY 10016, USA., Morrison CA; Skirball Institute for Biomolecular Medicine and Department of Cell Biology, NYU Grossman School of Medicine, 540 First Avenue, New York, NY 10016, USA., Ghosh N; Skirball Institute for Biomolecular Medicine and Department of Cell Biology, NYU Grossman School of Medicine, 540 First Avenue, New York, NY 10016, USA., Tea JS; Department of Molecular, Cell and Developmental Biology, University of California at Los Angeles, 405 Hilgard Avenue, Los Angeles, CA 90095, USA., Call GB; Department of Molecular, Cell and Developmental Biology, University of California at Los Angeles, 405 Hilgard Avenue, Los Angeles, CA 90095, USA., Treisman JE; Skirball Institute for Biomolecular Medicine and Department of Cell Biology, NYU Grossman School of Medicine, 540 First Avenue, New York, NY 10016, USA.
Publikováno v:
Development (Cambridge, England) [Development] 2022 Apr 01; Vol. 149 (7). Date of Electronic Publication: 2022 Mar 31.
Autor:
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. t.powles@qmul.ac.uk., Kockx M; HistogeneX N.V., Wilrijk, Belgium., Rodriguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain., Duran I; Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain., Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Pous AF; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Gravis G; Institut Paoli-Calmettes, Marseille, France., Herranz UA; Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain., Protheroe A; Department of Medical Oncology, Churchill Hospital, Oxford, UK., Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France., Maillet D; Department of Medical Oncology, Hospital Lyon Sud, Lyon, France., Mendez MJ; Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain., Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain., Linch M; Department of Medical Oncology, University College London Hospital, London, UK., Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., van Dam PJ; HistogeneX N.V., Wilrijk, Belgium., Stanoeva D; HistogeneX N.V., Wilrijk, Belgium., Daelemans S; HistogeneX N.V., Wilrijk, Belgium.; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium., Mariathasan S; Genentech, San Francisco, CA, USA., Tea JS; Genentech, San Francisco, CA, USA., Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Banchereau R; Genentech, San Francisco, CA, USA., Castellano D; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
Publikováno v:
Nature medicine [Nat Med] 2020 Jun; Vol. 26 (6), pp. 983.
Autor:
Phu L; Department of Microchemistry, Proteomics and Lipidomics, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA., Rose CM; Department of Microchemistry, Proteomics and Lipidomics, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA., Tea JS; Department of Clinical Operations, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA., Wall CE; Department of Neuroscience, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA., Verschueren E; Department of Microchemistry, Proteomics and Lipidomics, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA., Cheung TK; Department of Microchemistry, Proteomics and Lipidomics, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA., Kirkpatrick DS; Department of Microchemistry, Proteomics and Lipidomics, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: donaldk@gene.com., Bingol B; Department of Neuroscience, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: barisb@gene.com.
Publikováno v:
Molecular cell [Mol Cell] 2020 Mar 05; Vol. 77 (5), pp. 1107-1123.e10.
Autor:
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK. t.powles@qmul.ac.uk., Kockx M; HistogeneX N.V., Wilrijk, Belgium., Rodriguez-Vida A; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain., Duran I; Instituto de Biomedicina de Sevilla, IBiS, Hospital Universitario Virgen del Rocio, CSIC and Universidad de Sevilla, Seville, Spain., Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Van Der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Szabados B; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Pous AF; Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B.ARGO)-IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Gravis G; Institut Paoli-Calmettes, Marseille, France., Herranz UA; Department of Medical Oncology, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain., Protheroe A; Department of Medical Oncology, Churchill Hospital, Oxford, UK., Ravaud A; Department of Medical Oncology, Hopital Saint-Andre, University of Bordeaux-CHU Bordeaux, Bordeaux, France., Maillet D; Department of Medical Oncology, Hospital Lyon Sud, Lyon, France., Mendez MJ; Department of Medical Oncology, Reina Sofia University Hospital, Cordoba, Spain., Suarez C; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain., Linch M; Department of Medical Oncology, University College London Hospital, London, UK., Prendergast A; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., van Dam PJ; HistogeneX N.V., Wilrijk, Belgium., Stanoeva D; HistogeneX N.V., Wilrijk, Belgium., Daelemans S; HistogeneX N.V., Wilrijk, Belgium.; Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium., Mariathasan S; Genentech, San Francisco, CA, USA., Tea JS; Genentech, San Francisco, CA, USA., Mousa K; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London, UK., Banchereau R; Genentech, San Francisco, CA, USA., Castellano D; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain.
Publikováno v:
Nature medicine [Nat Med] 2019 Nov; Vol. 25 (11), pp. 1706-1714. Date of Electronic Publication: 2019 Nov 04.
Autor:
Cunningham CN; Department of Early Discovery Biochemistry, Genentech, Inc., 1 DNA Way South San Francisco, California 94080, USA., Baughman JM; Department of Protein Chemistry, Genentech, Inc., 1 DNA Way South San Francisco, California 94080, USA., Phu L; Department of Protein Chemistry, Genentech, Inc., 1 DNA Way South San Francisco, California 94080, USA., Tea JS; Department of Neuroscience, Genentech, Inc., 1 DNA Way South San Francisco, California 94080, USA., Yu C; Department of Structural Biology, Genentech, Inc., 1 DNA Way South San Francisco, California 94080, USA., Coons M; Department of Structural Biology, Genentech, Inc., 1 DNA Way South San Francisco, California 94080, USA., Kirkpatrick DS; Department of Protein Chemistry, Genentech, Inc., 1 DNA Way South San Francisco, California 94080, USA., Bingol B; Department of Neuroscience, Genentech, Inc., 1 DNA Way South San Francisco, California 94080, USA., Corn JE; Department of Early Discovery Biochemistry, Genentech, Inc., 1 DNA Way South San Francisco, California 94080, USA.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2015 Feb; Vol. 17 (2), pp. 160-9. Date of Electronic Publication: 2015 Jan 26.
Autor:
Tea JS; Department of Molecular, Cell and Developmental Biology (MCDB), University of California at Los Angeles (UCLA)., Cespedes A; Department of Molecular, Cell and Developmental Biology (MCDB), University of California at Los Angeles (UCLA)., Dawson D; Arizona College of Osteopathic Medicine (AZCOM), Midwestern University., Banerjee U; Department of Molecular, Cell and Developmental Biology (MCDB), University of California at Los Angeles (UCLA); MCDB, Broad Stem Cell Research Center, UCLA., Call GB; Arizona College of Osteopathic Medicine (AZCOM), Midwestern University; gcall@midwestern.edu.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2014 Nov 09 (93), pp. e52315. Date of Electronic Publication: 2014 Nov 09.
Autor:
Bingol B; 1] Department of Neuroscience, Genentech, Inc., South San Francisco, California 94080, USA [2]., Tea JS; 1] Department of Neuroscience, Genentech, Inc., South San Francisco, California 94080, USA [2]., Phu L; Department of Protein Chemistry, Genentech, Inc., South San Francisco, California 94080, USA., Reichelt M; Department of Pathology, Genentech, Inc., South San Francisco, California 94080, USA., Bakalarski CE; Department of Bioinformatics & Computational Biology, Genentech, Inc., South San Francisco, California 94080, USA., Song Q; Department of Non-Clinical Biostatistics, Genentech, Inc., South San Francisco, California 94080, USA., Foreman O; Department of Pathology, Genentech, Inc., South San Francisco, California 94080, USA., Kirkpatrick DS; Department of Protein Chemistry, Genentech, Inc., South San Francisco, California 94080, USA., Sheng M; Department of Neuroscience, Genentech, Inc., South San Francisco, California 94080, USA.
Publikováno v:
Nature [Nature] 2014 Jun 19; Vol. 510 (7505), pp. 370-5. Date of Electronic Publication: 2014 Jun 04.
Publikováno v:
Cold Spring Harbor protocols [Cold Spring Harb Protoc] 2014 Feb 01; Vol. 2014 (2), pp. 182-9. Date of Electronic Publication: 2014 Feb 01.